Lightnews — Scholar-powered news

Reposted by Amandine Luquiens

Nature @nature.com · 10d

Exclusive: "The CDC is far too important to just give up on" says Susan Monarez, who was director of the CDC for just 29 days under the current administration

go.nature.com/4pSmanQ

Exclusive: ex-CDC director talks about why she was fired

“I would never do that, as a scientist,” Susan Monarez says of being asked to approve changes to vaccine recommendations without knowing the details.

go.nature.com

2 51 200

Amandine Luquiens @luquiensa.bsky.social · Sep 8

@esbrasociety.bsky.social @benjaminrolland.bsky.social @pierremaurage.bsky.social @deminamimi.bsky.social

1

Amandine Luquiens @luquiensa.bsky.social · Sep 8

✨ Excited to present at ESBRA in Brussels our preliminary results:
👉 Patients’ early emergence of adaptive coping strategies predicts psilocybin treatment response at 3 months.
👉 First CNS BMQ signals related to neuroplasticity add to the picture.
Rich exchanges & inspiring encounters last week! 🌍💡

1 2

Amandine Luquiens @luquiensa.bsky.social · Aug 18

@psychedelique-fr.bsky.social @addictaide.bsky.social @addictionsfrance.bsky.social @zoe-dubus.bsky.social @existwell.bsky.social @drfriid.bsky.social @robincarhartharris.bsky.social @katrinpreller.bsky.social @luscher.bsky.social pubmed.ncbi.nlm.nih.gov/40702912/

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial - PubMed

Psilocybin-assisted psychotherapy appears feasible, acceptable, and safe in recently detoxified patients with comorbid alcohol use disorder and depression.

pubmed.ncbi.nlm.nih.gov

Amandine Luquiens @luquiensa.bsky.social · Aug 18

📰 Another one! Le Point adds to the wide media coverage of our Psilocybin–Alcohol–Depression study. l.lepoint.fr/DYL
France’s 1st psychedelic renaissance trial shows:
✨ society’s demand for new options as psychiatry & addiction care hit limits
✨ the need for rigorous science to test them.

Et si les champignons hallucinogènes devenaient un traitement efficace contre l’alcoolisme et la dépression ?

La recherche s’intéresse aux pouvoirs de la psilocybine – et autres psychédéliques interdits en usage clinique – sur les addictions et les dépressions.

l.lepoint.fr

1 2 2

Amandine Luquiens @luquiensa.bsky.social · Aug 16

👉 Putting an end to the guilt and stigma faced by people living with addiction, and moving away from terms like “responsible gambling.”
👉 Shedding light on the therapeutic hope carried by #psychedelics
@addictaide.bsky.social @addictionsfrance.bsky.social @chudenimes.bsky.social

Amandine Luquiens @luquiensa.bsky.social · Aug 16

In @nouvelobs.com, together with Amine Benyamina, we highlight key messages to guide public policies on #addiction.
www.nouvelobs.com/societe/2025...

« En addictologie, il y a un principe simple : pour faire avancer quelqu’un, on passe par la gratification, pas la punition »

Alors que le ministre de l’Intérieur assume d’avoir lancé une « campagne de culpabilisation » des usagers de cocaïne, les psychiatres Amine Benyamina et Amandine Luquiens questionnent nos politiques p...

www.nouvelobs.com

1 1

Reposted by Amandine Luquiens

Nature @nature.com · Aug 5

Nearly one-third of all retracted papers at PLoS ONE can be traced back to just 45 researchers who served as editors at the journal

go.nature.com/3UITVts

Exclusive: retraction-prone editors identified at megajournal PLoS ONE

Study says small editor group handled many problematic manuscripts — and a Nature investigation finds out who they are.

go.nature.com

4 41 100

Reposted by Amandine Luquiens

Addiction journal @addictionjournal.bsky.social · Jul 29

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial buff.ly/p13RswF
@luquiensa.bsky.social

buff.ly

4 3

Amandine Luquiens @luquiensa.bsky.social · Jul 24

The study was in people with alcohol use disorder recently detoxified and with persitent depressive symptoms Very promising results!

Endless thanks to our patients for their trust and to the whole team ❤️ #psychedelics #addictionresearch

1

Amandine Luquiens @luquiensa.bsky.social · Jul 24

Thrilled to share our newly published article in @AddictionJrnl : the first French study using psychedelics in a medical setting since research resumed.

At 3 months, abstinence rates were 5 times higher in the group receiving two 25 mg doses of psilocybin.
onlinelibrary.wiley.com/doi/10.1111/...

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantl...

onlinelibrary.wiley.com

1 2 4

Amandine Luquiens @luquiensa.bsky.social · Jul 12

Session on Gambling Disorder Treatment at the ICBA in Nantes this week. Psychotherapy, family approaches, contingency management, limitations of player account data—very insightful discussions! Many thanks to the organizers and speakers. @issba.bsky.social

1

Amandine Luquiens @luquiensa.bsky.social · Jun 20

Thanks to the organizers of the 5th International Multidisciplinary Symposium on excessive gambling for giving me the opportunity to present the results of the study DEBUTER, highlighting the role of gambling addiction in suicidal ideation among medical students

2

Amandine Luquiens @luquiensa.bsky.social · Jun 6

Thank you for this wonderful opportunity to present the results of the PAD study and to hear such inspiring talks!

1

Amandine Luquiens @luquiensa.bsky.social · Apr 7

du-diu-facmedecine.umontpellier.fr/diplome-addi...

DIU Addictions comportementales - DU DIU Faculté de Médecine de Montpellier-Nîmes

DIU Addictions comportementales - Ce DIU vise à fournir une formation théorique et clinique approfondie sur les addictions comportementales, en développant une approche critique et pluri-professionnel...

du-diu-facmedecine.umontpellier.fr

1

Amandine Luquiens @luquiensa.bsky.social · Apr 7

du-diu-facmedecine.umontpellier.fr/diplome-addi...

DIU Addictions comportementales - DU DIU Faculté de Médecine de Montpellier-Nîmes

DIU Addictions comportementales - Ce DIU vise à fournir une formation théorique et clinique approfondie sur les addictions comportementales, en développant une approche critique et pluri-professionnel...

du-diu-facmedecine.umontpellier.fr

Amandine Luquiens @luquiensa.bsky.social · Apr 7

En visio sur 2 modules et 3e module présentiel aux beaux jours à Montpellier @emelinechauchard.bsky.social @joelbillieux.bsky.social @marieroustide.bsky.social @gsescousse.bsky.social @gabthor.bsky.social @oulmann.bsky.social @loisfournier.bsky.social

2

Amandine Luquiens @luquiensa.bsky.social · Apr 7

J'ai le plaisir de vous inviter à vous inscrire au nouveau et seul diplôme interuniversitaire français "addictions comportementales"! Une formation théorique et clinique approfondie qui développe une approche critique et pluriprofessionnelle avec les plus grands experts francophones du champ!

2 3 2

Reposted by Amandine Luquiens

Rachel Hoopsick, PhD, MS, MPH, MCHES @rachelhoopsick.bsky.social · Apr 1

The entire National Survey on Drug Use and Health (NSDUH) team at SAMHSA was terminated today.

Do not listen to the platitudes of this administration when they say they care about drug overdose, addiction, mental health, or suicide.

18 300 560

Reposted by Amandine Luquiens

The New York Times @nytimes.com · Mar 12

The Substance Abuse and Mental Health Services Administration works on two of the most urgent U.S. health problems and has generally received bipartisan support. By the end of this week, the staff of the agency could be cut by 50%, according to senior staff members.

Federal Agency Dedicated to Mental Illness and Addiction Faces Huge Cuts

The Substance Abuse and Mental Health Services Administration has already closed offices and could see staff numbers reduced by 50 percent.

www.nytimes.com

44 120 220

Amandine Luquiens @luquiensa.bsky.social · Mar 9

#psychedelic #addiction

Amandine Luquiens @luquiensa.bsky.social · Mar 9

Very happy to speak at this conference to present the results of the PAD study!
thank you for inviting me @lucieberko.bsky.social @Afpbn

Lucie Berkovitch @lucieberko.bsky.social · Mar 9

🔬🧠 International experts such as @katrinpreller.bsky.social Guy Goodwin, David Erritzoe, Friederike Holze @drfriid.bsky.social, Amandine Luquiens @luquiensa.bsky.social, Lea Mertens, Christian Lüscher, Mickael Naassila and Matthias Liechti will present the latest news regarding psychedelics.

www.afpbn.org

1

Amandine Luquiens @luquiensa.bsky.social · Mar 7

@inserm.fr @umontpellier.bsky.social @doyensdemedecine.bsky.social @marieroustide.bsky.social

Amandine Luquiens @luquiensa.bsky.social · Mar 7

A reminder that academics have always been the first to be systematically targeted by autocrats upon taking power because knowledge and understanding serve as the true counterpower. Let us remember this and bend the course of history to avoid repeating the mistakes of the past.

1 1

Amandine Luquiens @luquiensa.bsky.social · Mar 7

#StandUpForScience Montpellier, France: Several hundred people—researchers, teachers, children, supporters, and institutional representatives, including the president of the University of Montpellier—gathered to support American scientists and stand up against censorship.

1 1 3